Inspire Medical Systems, Inc. (INSP)

NYSE · Medical Devices

61.63
-1.36 (-2.16%)
Updated Sep 1, 7:29 PM ET
AI Rating
Hold
Overall Score
49
Trend
50
Momentum
64
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 19, 2025 260 sessions Aug 31, 2026

AI Analysis

Inspire Medical Systems, Inc. is trading at $61.63, down 2.16% on the session. The 50 day average sits at $53.41 and the 200 day at $66.68, which puts the stock in a downtrend. RSI is at 65, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $60.01 with resistance near $63.20, so that band frames the current range. Average daily movement is roughly $2.53, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 49 out of 100 combines a trend score of 50, momentum of 64 and a risk score of 28.

Technical indicators

RSI (14)
65.0
strong
MACD
2.480
bearish crossover
SMA 20
60.26
SMA 50
53.41
SMA 200
66.68
downtrend
ATR (14)
2.53
avg daily range
Support
60.01
Resistance
63.20
Volume vs 20d
0.78x
below average
Volatility
84.1%
annualised
1 month
+25.45%
3 months
+54.24%

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.